|
Journal of Zhejiang University SCIENCE B
ISSN 1673-1581(Print), 1862-1783(Online), Monthly
2022 Vol.23 No.2 P.164-170
Chemerin promotes proliferation and migration of ovarian cancer cells by upregulating expression of PD-L1
Abstract: Ovarian cancer is the third-most-common malignant reproductive tumor in women. According to the American Cancer Society, it has the highest mortality rate of gynecological tumors. The five-year survival rate was only 29% during the period from 1975 to 2008 (
Key words: Ovarian cancer; Intraperitoneal tumor microenvironment; Chemerin; Programmed death ligand 1 (PD-L1)
创新点:首次发现了chemerin可以上调卵巢癌细胞PD-L1的表达,促进肿瘤增殖和迁移。这对进一步研究免疫抑制剂在卵巢癌治疗中的应用、卵巢癌的早期诊断,以及血清和腹水中chemerin的检测具有一定的指导意义。此外,chemerin结合其他脂肪因子是否能成为卵巢癌诊断的标志物,需进一步的研究证实。
方法:使用酶联免疫吸附剂测定(ELISA)检测卵巢癌患者腹水和血清中chemerin的含量;使用免疫组化检测卵巢癌肿瘤组织中chemerin和PD-L1的表达;使用免疫印迹法检测卵巢癌组织中PD-L1的表达及在HO8910和HO891PM细胞中chemerin表达的差异;利用浓度分别为0、10、50和100ng/mL外源性chemerin刺激HO8910和HO8910PM细胞;使用水溶性四唑(WST)检测细胞增殖;使用划痕实验检测细胞迁移功能;利用鬼笔环肽荧光染色在共聚焦显微镜下观察PD-L1敲除前后的HO8910和HO8910PM的细胞骨架变化;使用免疫印迹法检测细胞骨架蛋白的表达情况。
结论:Chemerin可以上调卵巢癌细胞PD-L1的表达,对肿瘤增殖和迁移具有促进作用。
关键词组:
References:
Open peer comments: Debate/Discuss/Question/Opinion
<1>
DOI:
10.1631/jzus.B2100392
CLC number:
Download Full Text:
Downloaded:
2136
Download summary:
<Click Here>Downloaded:
723Clicked:
3284
Cited:
0
On-line Access:
2024-08-27
Received:
2023-10-17
Revision Accepted:
2024-05-08
Crosschecked:
0000-00-00